Publicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (10)

2013

  1. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse

    American Journal of Hematology, Vol. 88, Núm. 5, pp. 359-364

2012

  1. Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 4, Núm. 1

2005

  1. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998

    Bone Marrow Transplantation, Vol. 35, Núm. 9, pp. 895-901

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886

2000

  1. Autologous stem cell transplantation for advanced Hodgkin's disease in children

    Bone Marrow Transplantation, Vol. 25, Núm. 1, pp. 31-34

  2. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support

    Journal of Clinical Oncology, Vol. 18, Núm. 18, pp. 3256-3261

1999

  1. Trasplante alogenico de medula osea en ninos con aplasia medular grave adquirida. Resultados a largo plazo

    Anales Espanoles de Pediatria, Vol. 50, Núm. 1, pp. 29-32

1998

  1. Treatment of Ph1-positive chronic myelogenous leukemia in children: Comparison between allogeneic bone marrow transplantation and conventional chemotherapy

    Haematologica, Vol. 83, Núm. 11, pp. 981-984

1996

  1. Trasplante alogénico de medula ósea versus autotrasplante en la leucemia aguda linfoblástica en segunda remisión en 113 niños: Resultados del Grupo Español de Trasplante de Medula Osea en Niños (GETMON)

    Sangre, Vol. 41, Núm. 2, pp. 101-108

1995

  1. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma

    Bone Marrow Transplantation, Vol. 15, Núm. 3, pp. 353-359